- Home
- ARQT vs ESBA Comparison
ARQT vs ESBA Comparison
Compare ARQT & ESBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- ESBA
- Stock Information
- Founded
- ARQT 2016
- ESBA N/A
- Country
- ARQT United States
- ESBA United States
- Employees
- ARQT N/A
- ESBA N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- ESBA
- Sector
- ARQT Health Care
- ESBA
- Exchange
- ARQT Nasdaq
- ESBA NYSE
- Market Cap
- ARQT 2.0B
- ESBA 2.2B
- IPO Year
- ARQT 2020
- ESBA 2013
- Fundamental
- Price
- ARQT $13.80
- ESBA $7.06
- Analyst Decision
- ARQT Strong Buy
- ESBA
- Analyst Count
- ARQT 6
- ESBA 0
- Target Price
- ARQT $18.80
- ESBA N/A
- AVG Volume (30 Days)
- ARQT 2.6M
- ESBA 7.9K
- Earning Date
- ARQT 05-13-2025
- ESBA 01-01-0001
- Dividend Yield
- ARQT N/A
- ESBA 1.98%
- EPS Growth
- ARQT N/A
- ESBA N/A
- EPS
- ARQT N/A
- ESBA 0.28
- Revenue
- ARQT $196,542,000.00
- ESBA $763,152,000.00
- Revenue This Year
- ARQT $60.21
- ESBA N/A
- Revenue Next Year
- ARQT $40.21
- ESBA N/A
- P/E Ratio
- ARQT N/A
- ESBA $25.25
- Revenue Growth
- ARQT 229.74
- ESBA 3.19
- 52 Week Low
- ARQT $6.99
- ESBA $6.39
- 52 Week High
- ARQT $17.75
- ESBA $11.50
- Technical
- Relative Strength Index (RSI)
- ARQT 46.44
- ESBA 36.97
- Support Level
- ARQT $12.51
- ESBA $6.39
- Resistance Level
- ARQT $13.67
- ESBA $7.07
- Average True Range (ATR)
- ARQT 1.43
- ESBA 0.26
- MACD
- ARQT -0.27
- ESBA 0.02
- Stochastic Oscillator
- ARQT 34.83
- ESBA 45.62
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About ESBA EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.